Expansion of the donor lung pool: Use of lungs from smokers

The Lancet

Volumn 380, Issue 9843, 2012, Pages 709-711

  Cypel, Marcelo ^a   Keshavjee, Shaf ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; NOTE; ORGAN DONOR; PRIORITY JOURNAL; SMOKING; SURVIVAL;

EID: 84865383428     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60650-3     Document Type: Note

References (18)

1. Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J, on behalf of members of the Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet 2012; published online May 29. DOI:10.1016/S0140- 6736(12)60160-3.
2. Eberlein M, Garrity ER, Orens JB. Lung allocation in the United States. Clin Chest Med 2011; 32: 213-22.
3. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20: 518-24. (Pubitemid 32410013)
4. Botha P, Trivedi D, Weir CJ, et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006; 131: 1154-60.
5. Aigner C, Winkler G, Jaksch P, et al. Extended donor criteria for lung transplantation\a clinical reality. Eur J Cardiothorac Surg 2005; 27: 757-61. (Pubitemid 40585666)
6. de Perrot M, Snell GI, Babcock WD, et al. Strategies to optimize the use of currently available lung donors. J Heart Lung Transplant 2004; 23: 1127-34. (Pubitemid 39346228)
7. Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006; 174: 710-16. (Pubitemid 44395340)
8. Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO. Organ donation and utilization in the United States, 1999-2008. Am J Transplant 2010; 10: 973-86.
9. Snell GI, Westall GP. Donor selection and management. Curr Opin Organ Transplant 2009; 14: 471-76.
10. Castaldi PJ, Demeo DL, Hersh CP, et al. Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax 2011; 66: 903-09.
11. Berman M, Goldsmith K, Jenkins D, et al. Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience. Ann Thorac Surg 2010; 90: 1786-92.
12. Schiavon M, Falcoz PE, Santelmo N, Massard G. Does the use of extended criteria donors influence early and long-term results of lung transplantation? Interact Cardiovasc Thorac Surg 2012; 14: 183-87.
13. Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009; 9: 1640-49.
14. de Perrot M, Liu M, Waddell T, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Cell Mol Biol 2003; 28: 616-25.
15. Christie JD, Sager JS, Kimmel SE, et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005; 127: 161-65. (Pubitemid 41724571)
16. Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: definition, risk factors, short-and long-term outcomes. Semin Respir Crit Care Med 2010; 31: 161-71.
17. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431-40.
18. Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009; 1: 1-9.